D 29 GLY 2 0.855 0.527 <=B
D 30 GLN 8 1.098 0.052 <=B
D 31 THR 3 0.706 0.280 <=B
D 32 ALA 0 -1.103 -0.976 <=B
D 33 GLY 1 -0.202 -0.293 <=B
D 34 GLU 7 -0.311 -1.080 <=B
D 35 LEU 10 -2.653 -3.498 <=B
D 36 TYR 3 -2.567 -2.617 <=B
D 37 GLN 6 -2.635 -3.022 <=B
D 38 ARG 14 -3.597 -4.794
D 39 TRP 15 -5.358 -6.466
D 40 GLU 6 -5.118 -5.219
D 41 ARG 8 -5.757 -6.015
D 42 TYR 23 -8.569 -10.228
D 43 ARG 10 -9.906 -9.916
D 44 ARG 7 -8.170 -8.035
D 45 GLU 15 -9.841 -10.434
D 46 CYS 24 -14.435 -15.535
D 47 GLN 7 -11.435 -10.925
D 48 GLU 6 -10.266 -9.775
D 49 THR 16 -13.797 -14.050
D 50 LEU 21 -13.121 -14.027
D 51 ALA 6 -10.478 -9.963
D 52 ALA 6 -9.867 -9.423
D 53 ALA 21 -12.187 -13.201
D 54 GLU 5 -10.377 -9.759
D 55 PRO 3 -10.280 -9.443
D 56 PRO 15 -10.498 -11.016
D 57 SER 0 -7.748 -6.857
D 58 GLY 8 -7.787 -7.812
D 59 LEU 10 -10.040 -10.035
D 60 ALA 16 -12.504 -12.906
D 61 CYS 25 -14.087 -15.342
D 62 ASN 5 -13.297 -12.343
D 63 GLY 19 -15.767 -16.139
D 64 SER 17 -15.219 -15.424
D 65 PHE 16 -14.780 -14.920
D 66 ASP 28 -13.684 -15.331
D 67 MET 1 -10.981 -9.833
D 68 TYR 17 -11.390 -12.035
D 69 VAL 28 -14.716 -16.244
D 70 CYS 21 -16.534 -17.048
D 71 TRP 31 -17.114 -18.711
D 72 ASP 15 -17.194 -16.942
D 73 TYR 14 -15.493 -15.322
D 74 ALA 26 -15.887 -17.050
D 75 ALA 2 -13.644 -12.305
D 76 PRO 9 -11.371 -11.098
D 77 ASN 1 -9.552 -8.569
D 78 ALA 16 -13.985 -14.216
D 79 THR 8 -15.141 -14.319
D 80 ALA 30 -17.294 -18.755
D 81 ARG 6 -15.905 -14.766
D 82 ALA 36 -16.185 -18.464
D 83 SER 13 -14.020 -13.902
D 84 CYS 18 -13.103 -13.667
D 85 PRO 29 -11.715 -13.703
D 86 TRP 9 -7.594 -7.756
D 87 TYR 20 -5.437 -7.112
D 88 LEU 28 -5.623 -8.197
D 89 PRO 13 -3.574 -4.658
D 90 TRP 13 -3.933 -4.976
D 91 HIS 16 -4.968 -6.237
D 92 HIS 1 -3.638 -3.334 <=B
D 93 HIS 12 -4.338 -5.219
D 94 VAL 22 -6.234 -8.047
D 95 ALA 5 -6.827 -6.617
D 96 ALA 1 -8.328 -7.486
D 97 GLY 22 -10.397 -11.732
D 98 PHE 9 -13.374 -12.871
D 99 VAL 28 -13.327 -15.015
D 100 LEU 8 -14.150 -13.443
D 101 ARG 30 -15.362 -17.045
D 102 GLN 7 -14.443 -13.587
D 103 CYS 20 -14.262 -14.922
D 104 GLY 9 -10.022 -9.904
D 105 SER 0 -7.548 -6.680
D 106 ASP 3 -7.146 -6.670
D 107 GLY 7 -11.103 -10.631
D 108 GLN 4 -10.775 -9.996
D 109 TRP 21 -13.214 -14.109
D 110 GLY 19 -11.517 -12.377
D 111 LEU 0 -10.611 -9.390
D 112 TRP 8 -11.516 -11.111
D 113 ARG 19 -11.027 -11.944
D 114 ASP 10 -10.708 -10.627
D 115 HIS 22 -11.330 -12.557
D 116 THR 2 -8.740 -7.965
D 117 GLN 17 -9.192 -10.090
D 118 CYS 22 -9.415 -10.862
D 119 GLU 11 -5.884 -6.472
D 120 ASN 9 -3.451 -4.089
D 121 PRO 10 -2.848 -3.671 <=B
D 122 GLU 7 -2.449 -2.972 <=B
D 123 LYS 13 -2.773 -3.949
D 124 ASN 7 -1.686 -2.297 <=B
D 125 GLU 1 -1.390 -1.345 <=B
D 126 ALA 0 -1.372 -1.214 <=B
D 127 PHE 5 -1.524 -1.924 <=B
D 128 LEU 5 -2.283 -2.596 <=B
D 129 ASP 3 -2.536 -2.589 <=B
D 130 GLN 5 -1.737 -2.112 <=B
D 131 ARG 6 -1.620 -2.124 <=B
D 132 LEU 5 -2.244 -2.561 <=B
D 133 ILE 6 -2.900 -3.257 <=B
D 134 LEU 6 -3.203 -3.525 <=B

Identified 23 B-Cell epitope residues out of 106 total residues